ANZEMET

Product NDC
30698-220
Requested package NDC
30698-220-10
11-digit product format
306980220
Labeler code
30698
Product ID
30698-220_3b3a8574-591c-46b7-99cc-adca27a22c01
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
dolasetron mesylate
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Validus Pharmaceuticals LLC
Application
NDA020623
Marketing category
NDA
Marketing start
1997-09-11
Marketing end
0000-00-00
Substance
DOLASETRON MESYLATE
Active strength
50 mg/1
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage30698-22030698-220-10IInactivated by FDA2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 9 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source dateCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31UExcluded because listing certification expired302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20UExcluded because listing certification expireded331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10UExcluded because listing certification expired0efc9e666f02…f202fb6c5f17…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020623-001ANZEMETDOLASETRON MESYLATE50MGTABLET / ORALRLD1997-09-11
N020623-002ANZEMETDOLASETRON MESYLATE100MGTABLET / ORALRLD1997-09-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-11011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-1131067a03dcf5…
2025-08-23 18:47 UTC2025-08N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-116a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-11fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-11b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-11b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-1103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-1103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-112680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-112680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-115bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-115bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-11d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-11d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-11d06236e962d9…
2024-10-29 15:01 UTC2024-10N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-11d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-1179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-1179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-11301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-11301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020623-001ANZEMET50MGTABLET / ORALRLD, RS1997-09-111e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-111e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020623-001ANZEMET50MGTABLET / ORALRLD, RS1997-09-118072bd15b7f6…
2024-05-31 18:47 UTC2024-05N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-118072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020623-001ANZEMET50MGTABLET / ORALRLD, RS1997-09-115c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-115c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020623-001ANZEMET50MGTABLET / ORALRLD, RS1997-09-115d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-115d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020623-001ANZEMET50MGTABLET / ORALRLD, RS1997-09-114b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-114b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-1174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-1174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020623-001ANZEMET50MGTABLET / ORALRLD, RS1997-09-11bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-11bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020623-001ANZEMET50MGTABLET / ORALRLD1997-09-11782e0a99824c…
2021-12-28 21:50 UTC2021-12N020623-002ANZEMET100MGTABLET / ORALRLD1997-09-11782e0a99824c…

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3a8edc88-eb72-f12c-6c3d-51e0d60f5286Product name120140508
b9dfd70a-61a0-c0b5-6d9b-517464af0607Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
30698-220-102025-01-30C16284748780-1ba0f9c33-0f61-a910-e053-dadaa90a0b85Anzemet
30698-220-102023-12-14C16284748780-1ba0f9c33-0f61-a910-e053-dadaa90a0b85Anzemet
30698-220-102023-01-30C16284748780-1ba0f9c33-0f61-a910-e053-dadaa90a0b85Anzemet

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
30698-220-10ANZEMET10 in 1 BOTTLETABLET, FILM COATED106

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
30698-220-10EA - Each30698-22068c9cdd9-0fc7-439d-9a58-437ec983c59a12022-06-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
30698-220ANZEMET (DOLASETRON MESYLATE) TABLET, FILM COATED [VALIDUS PHARMACEUTICALS LLC]6Legacy NDC, 1 package rows20231215_201b0eb8-4a1e-4e22-ab4b-addb642710d6.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
213091Anzemet 50 MG Oral TabletPSN201b0eb8-4a1e-4e22-ab4b-addb642710d66
310007dolasetron mesylate 50 MG Oral TabletPSN201b0eb8-4a1e-4e22-ab4b-addb642710d66
213091dolasetron 50 MG Oral Tablet [Anzemet]SBD201b0eb8-4a1e-4e22-ab4b-addb642710d66
310007dolasetron 50 MG Oral TabletSCD201b0eb8-4a1e-4e22-ab4b-addb642710d66
213091Anzemet 50 MG Oral TabletSY201b0eb8-4a1e-4e22-ab4b-addb642710d66

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
30698-220-103069802201010 TABLET, FILM COATED in 1 BOTTLE (30698-220-10) 1997-09-110000-00-00NoNoCurrent